LP
HUMAW icon

LMR Partners’s Humacyte Inc Warrant HUMAW Stock Holding History

LMR Partners’s Portfolio HUMAW Stock Details HUMAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-49,279
Closed -$29.6K – 1196
2024
Q1 		$29.6K Hold
49,279
– – ﹤0.01% 1016
2023
Q4 		$20.5K Hold
49,279
– – ﹤0.01% 834
2023
Q3 		$35.4K Hold
49,279
– – ﹤0.01% 750
2023
Q2 		$36K Hold
49,279
– – ﹤0.01% 690
2023
Q1 		$152K Sell
49,279
-721
-1% -$430 ﹤0.01% 889
2022
Q4 		$106K Hold
50,000
– – ﹤0.01% 1040
2022
Q3 		$163K Hold
50,000
– – ﹤0.01% 1029
2022
Q2 		$161K Hold
50,000
– – ﹤0.01% 1080
2022
Q1 		$353K Hold
50,000
– – ﹤0.01% 1044
2021
Q4 		$363K Sell
50,000
-119,683
-71% -$350K ﹤0.01% 984
2021
Q3 		$1.97M Buy
169,683
+119,683
+239% +$351K 0.02% 459
2021
Q2 		$140K Hold
50,000
– – ﹤0.01% 815
2021
Q1 		$146K Buy
+50,000
New +$118K ﹤0.01% 821

Other funds holding HUMAW

LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
PFM
Privium Fund Management Amsterdam, Netherlands $480M AUM 77.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LMR Partners's HUMAW Position: Q2 2024 in Review

LMR Partners sold out of Humacyte Inc Warrant (HUMAW) in Q2 2024, closing a stake of 49,279 shares — an estimated $29.6K sold.

LMR Partners first reported a position in HUMAW in Q1 2021 and held it in 13 quarters. The position peaked at $1.97M in Q3 2021. 10 funds tracked by Wall St. Rank hold HUMAW as of Q2 2024.

  • LMR Partners reported no remaining Humacyte Inc Warrant position as of Q2 2024 after selling out during the quarter.
  • LMR Partners sold 49,279 Humacyte Inc Warrant shares in Q2 2024, an estimated $29.6K.
  • LMR Partners first reported a position in Humacyte Inc Warrant in Q1 2021 and held it in 13 quarters.
  • LMR Partners's Humacyte Inc Warrant position peaked at $1.97M in Q3 2021.
  • 10 funds tracked by Wall St. Rank held Humacyte Inc Warrant as of Q2 2024.

Based on LMR Partners's 13F filing for Q2 2024, filed 14 Aug 2024.